 | Up a level |
Yousefzadeh, F. and Sahebolzamani, E. and Sadri, A. and Mortezaei, A. and Aqamolaei, A. and Mortazavi, S.H. and Shalbafan, M.R. and Ghaffari, S. and Alikhani, R. and Mousavi, S.B. and Naderi, S. and Shamabadi, A. and Jalilevand, S. and Akhondzadeh, S. (2020) 5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control. International Clinical Psychopharmacology, 35 (5). pp. 254-262.
Alikhani, R. and Salimi, A. and Hormati, A. and Aminnejad, R. (2020) Mental health advice for frontline healthcare providers caring for patients with COVID-19. Canadian Journal of Anesthesia, 67 (8). pp. 1068-1069.
